Quantitative bioactivity signatures of dietary supplements and natural products

Dietary Supplements and Natural Products have minor oversight of their safety and efficacy. We assembled a collection of Dietary Supplements and Natural Products (DSNP) as well as Traditional Chinese Medicinal (TCM) Plant extracts, which were screened against an in vitro panel of assays, including a liver cytochrome p450 enzyme panel, CAR/PXR signaling pathways, and P-gp transporter assays, to assess their activity. This pipeline facilitated the interrogation of Natural Product-Drug Interaction (NaPDI) through prominent metabolizing pathways. In addition, we compared the activity profiles of the DSNP/TCM substances with those of an approved drug collection. Many of the approved drugs have well-annotated mechanisms of action (MOA) while the MOAs for most of the DSNP and TCM samples remain unknown. Based on the premise that compounds with similar activity profiles tend to share similar targets or MOA, we clustered the library activity profiles to identify overlap with the NCATS Pharmaceutical Collection to predict the MOAs of the DSNP/TCM substances. Overall, we highlight four significant bioactivity profiles (measured by p-values) as examples of this prediction. These results can be used as a starting point for further exploration on the toxicity potential and clinical relevance of these substances.

[1]  H. Leier,et al.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants , 2022, Journal of natural products.

[2]  Emily M. Lee,et al.  Biological activity-based modeling identifies antiviral leads against SARS-CoV-2 , 2021, Nature Biotechnology.

[3]  Ruili Huang,et al.  Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library. , 2020, Biochemical pharmacology.

[4]  T. Hwang,et al.  Anti-inflammatory principles from Lindera aggregata. , 2020, Bioorganic & medicinal chemistry letters.

[5]  Jason R. Evans,et al.  National Cancer Institute (NCI) Program for Natural Products Discovery: Rapid Isolation and Identification of Biologically Active Natural Products from the NCI Prefractionated Library , 2020, ACS chemical biology.

[6]  H. Sitte,et al.  A critical examination of the main premises of Traditional Chinese Medicine , 2020, Wiener klinische Wochenschrift.

[7]  Nisha S. Sipes,et al.  Improving natural product research translation: From source to clinical trial , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Olivia W. Lee,et al.  A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein , 2019, Molecular Pharmacology.

[9]  A. Zakharov,et al.  A Comparative Study of Target Engagement Assays for HDAC1 Inhibitor Profiling , 2019, SLAS discovery : advancing life sciences R & D.

[10]  Ruili Huang,et al.  The NCATS Pharmaceutical Collection: a 10-year update. , 2019, Drug discovery today.

[11]  J. Alcorn,et al.  Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets , 2019, Pharmaceuticals.

[12]  H. Sheridan,et al.  Traditional Chinese Medicine: From Aqueous Extracts to Therapeutic Formulae , 2019, Plant Extracts.

[13]  V. Rishi,et al.  Herb-Drug Interactions and Hepatotoxicity. , 2019, Current drug metabolism.

[14]  S. Auerbach,et al.  Using Tox21 High-Throughput Screening Assays for the Evaluation of Botanical and Dietary Supplements , 2019, Applied in vitro toxicology.

[15]  Jin Wang,et al.  Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology , 2019, Pharmaceutical biology.

[16]  Ruili Huang,et al.  Identification of Modulators That Activate the Constitutive Androstane Receptor From the Tox21 10K Compound Library , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  R. Bailey.  Current regulatory guidelines and resources to support research of dietary supplements in the United States , 2018, Critical reviews in food science and nutrition.

[18]  Jared T. Shaw,et al.  Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space , 2018, ACS central science.

[19]  Hongbing Wang,et al.  The Roles of Xenobiotic Receptors: Beyond Chemical Disposition , 2018, Drug Metabolism and Disposition.

[20]  Olivia W. Lee,et al.  Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening , 2018, bioRxiv.

[21]  A. Rettie,et al.  Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product–Drug Interactions: A NaPDI Center Recommended Approach , 2018, Drug Metabolism and Disposition.

[22]  Jun Lu,et al.  Medicinal Components and Pharmacological Effects of Rosa rugosa , 2018, Records of Natural Products.

[23]  M. Aschner,et al.  Atropa belladonna neurotoxicity: Implications to neurological disorders. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  Z. Selamoğlu,et al.  Astragalin: A Bioactive Phytochemical with Potential Therapeutic Activities , 2018, Advances in pharmacological sciences.

[25]  W. Xie,et al.  PXR as a mediator of herb–drug interaction , 2017, Journal of food and drug analysis.

[26]  Jihan Huang,et al.  The Characteristics of TCM Clinical Trials: A Systematic Review of ClinicalTrials.gov , 2017, Evidence-based complementary and alternative medicine : eCAM.

[27]  Gary A. Smith,et al.  An Increase in Dietary Supplement Exposures Reported to US Poison Control Centers , 2017, Journal of Medical Toxicology.

[28]  D. Newman.  Screening and identification of novel biologically active natural compounds , 2017, F1000Research.

[29]  K. Ahn,et al.  Cynanchum atratum inhibits the development of atopic dermatitis in 2,4-dinitrochlorobenzene-induced mice. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  K. Dalhoff,et al.  Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions , 2017, Drugs.

[31]  Amrinder Singh,et al.  Herb-Drug Interactions of Commonly Used Chinese Medicinal Herbs. , 2017, International review of neurobiology.

[32]  Mengmeng Du,et al.  Trends in Dietary Supplement Use Among US Adults From 1999-2012. , 2016, JAMA.

[33]  Zian Xia,et al.  Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review , 2016, Neuropsychiatric disease and treatment.

[34]  Jinxiu Lei,et al.  Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor. , 2016, Biochimica et biophysica acta.

[35]  H. Bi,et al.  PXR- and CAR-mediated herbal effect on human diseases. , 2016, Biochimica et biophysica acta.

[36]  Q. Liu,et al.  Composition and Insecticidal Activity of the Essential Oil of Lindera aggregata Root Tubers against Sitophilus zeamais and Tribolium castaneum , 2016 .

[37]  K. Fischbeck,et al.  CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy , 2016, Neurobiology of Disease.

[38]  L. Hanuš,et al.  Cannabinoids and Cytochrome P450 Interactions. , 2016, Current drug metabolism.

[39]  Ruili Huang,et al.  Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization , 2016, Nature Communications.

[40]  R. V. van Breemen,et al.  Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements , 2015, Drug Metabolism and Disposition.

[41]  Ruili Huang,et al.  A Quantitative High-Throughput Screening Data Analysis Pipeline for Activity Profiling. , 2016, Methods in molecular biology.

[42]  M. Xia,et al.  Quantitative High-Throughput Luciferase Screening in Identifying CAR Modulators. , 2016, Methods in molecular biology.

[43]  Filip Stefaniak,et al.  Prediction of Compounds Activity in Nuclear Receptor Signaling and Stress Pathway Assays Using Machine Learning Algorithms and Low-Dimensional Molecular Descriptors , 2015, Front. Environ. Sci..

[44]  X. Su,et al.  Actinoramide A Identified as a Potent Antimalarial from Titration-Based Screening of Marine Natural Product Extracts. , 2015, Journal of Natural Products.

[45]  Nadine Shehab,et al.  Emergency Department Visits for Adverse Events Related to Dietary Supplements. , 2015, New England Journal of Medicine.

[46]  M. Xia,et al.  Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells , 2015, Cell Biology and Toxicology.

[47]  Xinlai Cheng,et al.  Natural lignans from Arctium lappa modulate P-glycoprotein efflux function in multidrug resistant cancer cells. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[48]  V. Prachayasittikul,et al.  Cytochrome P450 enzyme mediated herbal drug interactions (Part 2) , 2014, EXCLI journal.

[49]  Henry H. N. Lam,et al.  Quality Control of Danggui Buxue Tang, a Traditional Chinese Medicine Decoction, by 1H-NMR Metabolic Profiling , 2014, Evidence-based complementary and alternative medicine : eCAM.

[50]  Zhihao Liu,et al.  Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp. , 2014, Toxicology and applied pharmacology.

[51]  Bingyou Yang,et al.  P‑glycoprotein inhibition increases the transport of dauricine across the blood‑brain barrier. , 2014, Molecular medicine reports.

[52]  Mark S Butler,et al.  Natural Product Libraries: Assembly, Maintenance, and Screening. , 2013, Planta Medica.

[53]  Ruili Huang,et al.  The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality. , 2013, Drug discovery today.

[54]  Jake E. Delmore,et al.  The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias , 2013, Cancer Chemotherapy and Pharmacology.

[55]  M. Wink,et al.  An isoquinoline alkaloid from the Chinese herbal plant Corydalis yanhusuo W.T. Wang inhibits P-glycoprotein and multidrug resistance-associate protein 1. , 2013, Food chemistry.

[56]  Yitao Wang,et al.  Chemical components, pharmacological properties, and nanoparticulate delivery systems of Brucea javanica , 2013, International journal of nanomedicine.

[57]  D. Auld,et al.  Bioluminescent assays for cytochrome P450 enzymes. , 2013, Methods in molecular biology.

[58]  S. Iturria,et al.  HTS Assay Validation , 2012 .

[59]  P. Fasinu,et al.  An Overview of the Evidence and Mechanisms of Herb–Drug Interactions , 2012, Front. Pharmacol..

[60]  M. Xia,et al.  Assessment of compound hepatotoxicity using human plateable cryopreserved hepatocytes in a 1536-well-plate format. , 2012, Assay and drug development technologies.

[61]  C. Klaassen,et al.  Repeated administration of berberine inhibits cytochromes P450 in humans , 2012, European Journal of Clinical Pharmacology.

[62]  M. Mcdougall,et al.  Proluciferin Acetals as Bioluminogenic Substrates for Cytochrome P450 Activity and Probes for CYP3A Inhibition , 2011, Drug Metabolism and Disposition.

[63]  James Inglese,et al.  Titration-based screening for evaluation of natural product extracts: identification of an aspulvinone family of luciferase inhibitors. , 2011, Chemistry & biology.

[64]  S. Zeng,et al.  Identification of novel pregnane X receptor activators from traditional Chinese medicines. , 2011, Journal of ethnopharmacology.

[65]  Ruili Huang,et al.  Chemical Genomics Profiling of Environmental Chemical Modulation of Human Nuclear Receptors , 2011, Environmental health perspectives.

[66]  Yeng Chen,et al.  Extraction, isolation and characterization of bioactive compounds from plants' extracts. , 2010, African journal of traditional, complementary, and alternative medicines : AJTCAM.

[67]  Jane A. Craycroft,et al.  Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation--rationale, methods and preliminary results from a Sino-American collaboration. , 2011, Fitoterapia.

[68]  K. Bley,et al.  Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin , 2010, Xenobiotica; the fate of foreign compounds in biological systems.

[69]  Ruili Huang,et al.  A Grid Algorithm for High Throughput Fitting of Dose-Response Curve Data , 2010, Current chemical genomics.

[70]  G. Wallukat,et al.  Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids* , 2010, The Journal of Biological Chemistry.

[71]  W. Qiu,et al.  Effect of berberine on the pharmacokinetics of substrates of CYP3A and P‐gp , 2009, Phytotherapy research : PTR.

[72]  Ruili Huang,et al.  Comprehensive Characterization of Cytochrome P450 Isozyme Selectivity across Chemical Libraries , 2009, Nature Biotechnology.

[73]  Thomas K. H. Chang.  Activation of Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) by Herbal Medicines , 2009, The AAPS Journal.

[74]  Christopher P Austin,et al.  Monitoring Compound Integrity With Cytochrome P450 Assays and qHTS , 2009, Journal of biomolecular screening.

[75]  D. Auld,et al.  Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression , 2009, Proceedings of the National Academy of Sciences.

[76]  Taosheng Chen,et al.  Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells* , 2008, Journal of Biological Chemistry.

[77]  R. Nowack.  Review Article: Cytochrome P450 enzyme, and transport protein mediated herb–drug interactions in renal transplant patients: Grapefruit juice, St John's Wort – and beyond! (Review Article) , 2008, Nephrology.

[78]  Sam Michael,et al.  Compound Management for Quantitative High-Throughput Screening , 2008, JALA.

[79]  Christopher P Austin,et al.  Characterization of chemical libraries for luciferase inhibitory activity. , 2008, Journal of medicinal chemistry.

[80]  J. Staudinger,et al.  Pregnane X receptor and natural products: beyond drug–drug interactions , 2006, Expert opinion on drug metabolism & toxicology.

[81]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[82]  David J. Liu,et al.  Luminogenic cytochrome P450 assays , 2006, Expert opinion on drug metabolism & toxicology.

[83]  R. Tirona,et al.  Herbal product-drug interactions mediated by induction. , 2006, British journal of clinical pharmacology.

[84]  S. Kadota,et al.  Cytochrome P450 2D6 (CYP2D6) inhibitory constituents of Catharanthus roseus. , 2005, Biological & pharmaceutical bulletin.

[85]  C. Austin,et al.  Minimum Significant Ratio – A Statistic to Assess Assay Variability -- Assay Guidance Manual , 2013 .

[86]  D. Bojanic.  Handbook of Drug Screening. , 2001, Drug discovery today.

[87]  A. Lennard.  Pain Procedures in Clinical Practice , 2000 .